|

Volume 1 * Number 1
Words from Dr.
Biddle:
Wow,
what an amazing journey since our last newsletter four months
ago! Moving the clinic certainly was an adventure and I'm loving
our new, homey location on South French Broad Avenue.
I want to share with you some of the recent teachings the
universe has been showing me, medically that is. I've noticed
that patients tend to come to me in groups of 3 or 4 at a time
with certain diagnoses. Remarkably, one of two things usually
happen with each diagnosis group: either the patients show up
right after I'm exposed to some really good article about
natural or advanced treatment options, or the patients bring me
a packet of research they've been gathering on their diagnosis
and ask me to help them implement an innovative treatment
program. They usually have a story about their
"regular" doctor being unwilling to take a serious
look at their information, either due to skepticism or time
constraints. I sympathize with constrictions around time, but
find that I'm usually amply rewarded when I finally manage to
look at the data.
Over the last quarter, the topics that have been most obvious
for teaching me new treatment strategies include hyperlipidemia
(i.e. high cholesterol), subclinical hypothyroidism (i.e.
Wilson's syndrome), rheumatoid arthritis and scleroderma, and
Hepatitis C.
Hyperlipidemia: We have great success with
clients dropping their cholesterol and lipid values by following
our adequate-protein, fibrous-carbohydrate, healthy-fat
dietary philosophy. However, some patients still need
additional help with their lipid levels, either due to genetics
or dietary indiscretion. In these cases, the studies and our
experience both show great results with using Gugulipid (an
herb from India) and/or Niasafe (a safe form of non-flush
Niacin; see Anne's article this edition). If your lipid levels
are still high or borderline after dietary changes, consider
adding one or both of these herbs, which compete favorably with
prescription medications for results, but beat the heck out of
them in their absence of uncomfortable or unhealthy "side
effects."
Subclinical Hypothyroidism (Wilson's Syndrome):
Here's--one of those diagnosis and treatment protocols that
defies recognition in mainstream medicine by invoking the adage
of "all evidence that does not fit the ruling paradigm
will be ignored." In this condition, patients have
normal thyroid labs but low body temperatures, usually with
numerous or "vague" complaints that don't fit into a
conveniently classical diagnostic constellation. In other words,
conventional physicians experience these patients as complaining
and frustrating, because they don't have a good label and
they're not getting better with symptomatic band-aids. Here's
the theory behind Wilson's Syndrome: a body has a defect
converting thyroid hormone (T4) to its more active form of T3.
In brief, the thyroid hormone receptors throughout the body
don't get stimulated enough in spite of normal lab values, so
metabolism is slow, temperature is low, enzymes throughout the
body perform below par, and symptoms are diffuse. Treatment
consists of taking several cycles of T3, about 2-3 weeks per
cycle. Symptoms often resolve when the body is able to restore
normal operating temperatures and enzymes work appropriately.
Although it is a complex treatment program and many patients do
report uncomfortable symptoms during treatment, results can be
dramatically positive. (see http://www.wilsonsyndrome.com)
Rheumatoid Arthritis and Scleroderma: A new
patient brought me a wonderful book entitled "A New
Arthritis Breakthrough" by Henry Scammell, documenting Dr.
Thomas McPherson Brown's novel treatment approach to rheumatoid
arthritis (RA) as an allergic autoimmune response to chronic
mycoplasma infection, as well as his 50-year battle with the
arthritis establishment. My favorite chapter is "In Defense
of Heresy," which gives clear examples of how most really
useful medical innovations are first ignored, suppressed, and
even persecuted. In this case, the data is clear that many
cases, perhaps even the majority of cases, of RA are associated
with chronic infection with species of mycoplasma. Even though
it's clear that Strep infections initiate, rheumatic arthritis,
spirochete infections cause Lyme arthritis, and gut infections
can trigger ankylosing spondylitis, the American Rheumatology
Association has been vociferous in its unwillingness to even
consider the possibility that long-term antibiotic therapy might
improve many cases of RA. I'm personally excited to be exposed
to this data and hope it will be useful for my patients. (see
http://www.roadback.org and http://www.rheumatic.org)
It's already clear that 85% of all ulcers are caused by chronic
infection with Helicobacter pylori and it's now becoming clear
that a significant percentage of heart disease is being caused
by chronic infection with Chlamydia pneumoniae. It's odd
for me as the "natural" medicine doctor to be
prescribing extended courses of antibiotics, but that's part of
practicing Integrative Medicine, using what works and will get
the best result for the patient.
Hepatitis C: With this diagnosis, it's not
so much that I've come across any spectacular new treatments
recently, but it has come to my attention just how often
Hepatitis C goes undiagnosed. This month I had three healthy and
asymptomatic clients present after having a positive test for
Hep C during an insurance physical or donating blood. This is a
sneaky infection in several ways. The first is that less than
20% of infected individuals ever have symptoms. The second is
that we don't really know how most people get it, since most
carriers never had a blood transfusion. Sexual transmission is
probably the most common route, but partners of carriers often
remain uninfected for decades. The third sneaky aspect of Hep C
is that it tends to mutate inside your body, thereby escaping
the immune system's attempts to abolish it. Thus far, only about
15% of infected people seem able to spontaneously and completely
cure themselves of the infection, while 20% develop cirrhosis
after 20 years.
What to do if you come up with a positive test? First of all,
stay calm and do further testing to see if you're already in the
15% spontaneous cure category. This test is the Hep C serum
RNA level hypolymerase chain reaction (PCR). Next, get
further educated at http://www.shn.net or see the NIH Consensus
Statement at http://odp.od.nih. gov/consensus/statements/cdc/105/105
stmt.htmI (whew!) Unfortunately, conventional therapy with
alpha-interferon only offers modest gain with great expense and
side effects, although recent addition of ribavirin has improved
results.
Finally, start on a program to increase your odds of being a
spontaneous healer, or at least of surviving a normal lifespan
with normal liver function, thereby eventually dying with
Hep C rather than from it. At CCMM we focus on three
basic strategies for somebody in this situation: support the
immune system, support liver function, and suppress viral
replication. The specifics are too complex to describe here and
are of course individualized to the client, but I'm convinced
that "we" could do much better than just 15%
spontaneous healing if "we" did a better job of
providing the body what it needs to do the job.
In summary, I'm grateful that my clients continue to educate me
as I endlessly refine my "practice" of Integrative
Medicine. At times this means walking into territory on
"the road less traveled" and risking medical heresy,
yet the reward is in consistently seeing improvements in
patients who would typically be expected to have only
progressive deterioration.
In Good Health,
Dr. Jim Biddle
Friends
of Chelation
There is a new local chapter forming of this nationwide
non-profit organization that is dedicated to educating the lay
public and the medical establishment about the potential
benefits of IV EDTA Chelation Therapy, especially in reversing
vascular disease. This is also a great step to take in.
defending your right to access and freedom of choice in health
care. All patients interested in joining this chapter ($10
yearly dues), please call Ms. Eleanor Lloyd at 828-274-2088.
CCMM
Offers EAV Testing
As part of our ongoing effort to provide the best treatment
options for our patients, CCMM is now offering EAV testing.
Testing consists of applying "sensors" to the body in
order to monitor electrical current. Afterward, an analysis is
generated by the computer, based on various readings and
comparisons. Information helpful to prescribing supplements and
medical treatments can be quickly obtained. For more information
about this service, or to schedule an appointment, please call
the office at (828) 252-5545.
Nutrition
Corner with Anne Walch, PA-C -- Niasafe
Niasafe, a brand of inositol hexaniacinate, is one of the three
main supplemental forms of Vitamin B3 (niacin). The other forms
are niacin (nicotinic acid) and niacinamide. Niacin and inositol
hexaniacinate (INH) have primarily been used in nutritionaI-based
medicine to treat elevated cholesterol and triglycerides. The
lipid lowering effects of niacin were reported more than 30
years ago. Specifically, niacin was found to lower LDL
cholesterol, Lp(a) lipoprotein, triglycerides, and fibrinogen
levels, as well as raising HDL cholesterol levels -- good things
for the heart!! In recent studies comparing niacin to the new
lipid-lowering prescription drugs, niacin compared favorably, if
not better, in improving the lipid values, which are indicators
for coronary heart disease. However, drawbacks to niacin at the
full therapeutic dose of 1.5 to 3 grams are flushing of the head
and neck. Less common side effects include skin rashes,
intestinal disturbances, fatigue, lab abnormalities, and,
rarely,liver damage. A beneficial alternative to conventional
niacin therapy is Niasafe, or inositol hexaniacinate.
This is a form of niacin composed of six nicotinic acid
molecules bound to and surrounding one molecule of inositol, an
unofficial B vitamin. This form of niacin has been used in
Europe for over thirty years with an excellent safety record.
Niasafe is just as effective as niacin in lowering LDL
cholesterol, Lp(a) lipoprotein, triglycerides, and fibrinogen
levels and increasing HDL cholesterol, but with the big
advantage that it is safer and much better tolerated. Typical
doses of Niasafe are 500mg three times a day with meals.
(Because niacin can impair glucose tolerance it should be used
cautiously in diabetics under a physician's care. Niacin should
not be used in individuals with preexisting liver disease or
elevation in liver enzymes; gout; or peptic ulcers. Periodic
checking of cholesterol and liver function tests are indicated
when high dose niacin or inositol hexaniacinate therapy is
used.)
Healthy
Notes is published by the Carolina Center for Metabolic
Medicine, PA. All material is the exclusive property of the
Carolina Center for Metabolic Medicine, and may not be reprinted
in any media without expressed written permission. The
information and advice presented in this newsletter is for
informational purposes only. Consult a physician prior to
starting any diet or medical treatment plan.
|